The Acinetobacter baumannii group: a systemic review

BACKGROUND: The Acinetobacter baumannii group, including Acinetobacter baumannii, Acinetobacter genomospecies 3 and 13TU, is phenotypically indistinguishable and uniformly identified as Acinetobacter baumannii by laboratories of clinical microbiology. This review aimed to demonstrate the differences...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hua-zhong, Zhang, Jin-song, Qiao, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Affiliated Hospital of Zhejiang University School of Medicine 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129852/
https://www.ncbi.nlm.nih.gov/pubmed/25215113
http://dx.doi.org/10.5847/wjem.j.issn.1920-8642.2013.03.002
Descripción
Sumario:BACKGROUND: The Acinetobacter baumannii group, including Acinetobacter baumannii, Acinetobacter genomospecies 3 and 13TU, is phenotypically indistinguishable and uniformly identified as Acinetobacter baumannii by laboratories of clinical microbiology. This review aimed to demonstrate the differences among them. METHODS: Literatures associated with the Acinetobacter baumannii group were identified and selected from PubMed databases and relevant journals. RESULTS: Acinetobacter genospecies 3 and 13TU possess a certain proportion in clinical isolates. There were considerable differences in epidemiologic features, clinical manifestations, antimicrobial resistances and therapeutic options among the Acinetobacter baumannii group. Compared with Acinetobacter genomospecies 3 and 13TU, Acinetobacter baumannii with a higher resistance to antimicrobial agents are easier to be treated inappropriately, and present a worse outcome in patients. CONCLUSION: The Acinetobacter baumannii group comprises three distinct clinical entities, and their clinical value are not equal.

Ejemplares similares